UGEL, Stefano
 Distribuzione geografica
Continente #
EU - Europa 5.426
NA - Nord America 4.803
AS - Asia 3.388
SA - Sud America 494
AF - Africa 127
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.264
Nazione #
US - Stati Uniti d'America 4.685
RU - Federazione Russa 2.092
SG - Singapore 1.307
CN - Cina 920
IT - Italia 880
GB - Regno Unito 878
BR - Brasile 386
DE - Germania 370
VN - Vietnam 364
HK - Hong Kong 344
FI - Finlandia 229
FR - Francia 212
IE - Irlanda 206
SE - Svezia 201
KR - Corea 103
NL - Olanda 101
IN - India 66
CA - Canada 53
ID - Indonesia 52
UA - Ucraina 50
MX - Messico 41
JP - Giappone 39
TR - Turchia 39
AT - Austria 38
AR - Argentina 35
BD - Bangladesh 34
ZA - Sudafrica 33
ES - Italia 30
BE - Belgio 29
PL - Polonia 26
NG - Nigeria 24
IQ - Iraq 21
AU - Australia 20
CO - Colombia 20
TG - Togo 18
CZ - Repubblica Ceca 17
BJ - Benin 15
PK - Pakistan 14
SA - Arabia Saudita 14
EC - Ecuador 13
VE - Venezuela 12
MA - Marocco 10
PH - Filippine 10
PY - Paraguay 10
CH - Svizzera 9
IL - Israele 9
LT - Lituania 8
TN - Tunisia 8
PE - Perù 7
PT - Portogallo 7
CL - Cile 6
EG - Egitto 6
JM - Giamaica 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
MY - Malesia 5
PS - Palestinian Territory 5
CY - Cipro 4
HR - Croazia 4
IR - Iran 4
OM - Oman 4
RO - Romania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
PA - Panama 3
TW - Taiwan 3
BG - Bulgaria 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
JO - Giordania 2
KG - Kirghizistan 2
LU - Lussemburgo 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
SI - Slovenia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AD - Andorra 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BY - Bielorussia 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GM - Gambi 1
Totale 14.248
Città #
Moscow 763
Southend 724
Ashburn 704
Singapore 650
San Jose 485
Verona 485
Chandler 408
Dallas 403
Hong Kong 330
Munich 207
Dublin 198
Beijing 191
Jacksonville 186
New York 175
Woodbridge 159
The Dalles 156
Ann Arbor 141
Los Angeles 121
Helsinki 107
Council Bluffs 99
Houston 96
Ho Chi Minh City 88
Redmond 84
Hanoi 63
Lawrence 61
Princeton 61
Jinan 58
Wilmington 58
Shenyang 51
Orem 49
Nanjing 42
São Paulo 42
Jakarta 41
Milan 41
Buffalo 40
Redondo Beach 40
London 39
Santa Clara 37
Turku 36
Dong Ket 34
Tokyo 34
Amsterdam 32
Brussels 29
Columbus 29
Denver 28
Lappeenranta 28
Tianjin 28
Chicago 26
Frankfurt am Main 26
Johannesburg 26
Brooklyn 25
Zhengzhou 25
Montreal 24
Abuja 23
Atlanta 23
Chennai 22
Hebei 22
Nanchang 21
Phoenix 21
Vienna 21
Ningbo 20
Warsaw 20
Haiphong 19
Hangzhou 19
Mexico City 19
Washington 19
Haikou 18
Lomé 18
Stockholm 18
Guangzhou 17
Nuremberg 17
Redwood City 17
Sindelfingen 17
Changsha 15
Cotonou 15
Manchester 15
Paris 15
Seattle 15
Seoul 15
Boston 14
Da Nang 14
Jiaxing 14
Poplar 14
Toronto 14
San Francisco 13
Boydton 12
Sydney 12
Ankara 11
Boardman 11
Madrid 11
Norwalk 11
Padova 11
Rio de Janeiro 11
Taiyuan 11
Baghdad 10
Querétaro 10
Rome 10
Sant'Ambrogio di Valpolicella 10
Taizhou 10
Brasília 9
Totale 8.837
Nome #
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 307
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 294
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 291
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 286
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 281
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 258
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 251
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 250
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 237
Deciphering the state of immune silence in fatal COVID-19 patients 228
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 223
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 219
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 215
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes. 213
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 213
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 211
Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens 211
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 204
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 203
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 197
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 195
Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation 192
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 190
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 188
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice 180
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 179
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 179
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 174
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia 171
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 171
MDSCs in cancer: Conceiving new prognostic and therapeutic targets 167
Anti-telomerase T cells adoptive transfer 162
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 161
The Endless Saga of Monocyte Diversity 160
Discovery of highly potent benzimidazole derivatives as indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to in vivo pharmacodynamic activity 160
Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report 159
Circulating IgG4+ Plasmablast Count as a Diagnostic Tool in Autoimmune Pancreatitis 157
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. 157
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. 156
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis 155
Local ablation disrupts immune evasion in pancreatic cancer 154
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 150
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 148
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 147
The Engagement Between MDSCs and Metastases: Partners in Crime 144
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 142
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment 142
HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development 141
Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies 139
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. 139
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages 136
Role of arginine metabolism in immunity and immunopathology. 134
Therapeutic targeting of myeloid-derived suppressor cells. 132
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. 132
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. 132
Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature 131
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells 131
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer. 130
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. 129
Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention. 129
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines 129
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 128
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 128
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo 128
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation 126
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer. 126
T-cell tracking using Cerenkov and radioluminescence imaging 126
Interaction of human pancreatic ductal adenocarcinoma cells with polymeric scaffolds to develop tissue-engineered cancer models. 124
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance 121
"Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer 121
Phenotypical Characterization and Isolation of Tumor-Derived Mouse Myeloid-Derived Suppressor Cells 121
Immune-guided therapy of COVID-19. 119
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells 117
The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO. 115
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade 115
A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment 114
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1 114
Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound 109
Tumor-Induced Myeloid-Derived Suppressor Cells 107
The dark side of tumor-associated endothelial cells 106
Moonlighting Proteins Are Important Players in Cancer Immunology 105
HER2 Aberrations in NSCLC: So Close Yet So Far 98
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy 95
Monocytes in the Tumor Microenvironment 95
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response 93
GateMeClass: Gate Mining and Classification of cytometry data 92
Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines 83
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 81
Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells 81
Pre-diagnostic prognostic value of leukocytes count and neutrophil-to-lymphocyte ratio in patients who develop colorectal cancer 72
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses 69
B-CELL RECEPTOR SIGNALING ACTIVITY IDENTIFIES PATIENTS WITH MANTLE CELL LYMPHOMA AT HIGHER RISK OF PROGRESSION 62
A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2- ORCHESTRA Project 39
Telehealth-delivered exercise and nutrition intervention to improve outcomes in patients with early stage non-small cell lung cancer: protocol for the multicentre STARLighT phase II (neoadjuvant) and phase III (adjuvant) trial 34
Corneal regenerative contribution of endogenous and grafted limbal-corneal cells in a mouse model of simple limbal-corneal epithelial transplantation 21
c-FLIP as a master regulator of immune homeostasis and disease mechanisms 3
Totale 14.484
Categoria #
all - tutte 46.293
article - articoli 42.693
book - libri 0
conference - conferenze 1.528
curatela - curatele 0
other - altro 1.575
patent - brevetti 0
selected - selezionate 0
volume - volumi 497
Totale 92.586


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021157 0 0 0 0 0 0 0 0 0 23 48 86
2021/2022553 38 152 37 21 18 12 17 38 49 17 41 113
2022/20231.268 72 165 105 221 102 310 23 71 130 8 38 23
2023/2024921 34 51 63 89 121 188 66 65 15 70 131 28
2024/20252.651 118 108 139 393 100 118 255 208 375 135 255 447
2025/20266.712 440 358 443 1.131 1.849 428 699 379 547 438 0 0
Totale 14.484